Skip to main content
Cancer Medicine logoLink to Cancer Medicine
. 2018 Oct 2;7(11):5812–5819. doi: 10.1002/cam4.1660

Determinants of mobile technology use and smartphone application interest in cancer patients

Nirupa Jaya Raghunathan 1,, Deborah Korenstein 1, Qing S Li 1, Emily S Tonorezos 1,2, Jun J Mao 1
PMCID: PMC6246952  PMID: 30280495

Abstract

Background

Supportive care is a critical component of the treatment of cancer patients that is underutilized; patient lack of information about these services is an important barrier. Mobile technologies may be useful tools for delivering information, but cancer patient use of and interest in using them to learn about supportive care services have not been described. This study evaluates factors associated with cancer patient use of mobile technologies and interest in smartphone applications for information delivery about supportive care.

Methods

We conducted a cross‐sectional survey among cancer patients from one urban academic hospital and 11 community hospitals. Patients self‐reported use of mobile technologies and interest in smartphone applications. Multivariate logistic analysis was used to identify determinants of mobile technology use and smartphone interest.

Results

Among 631 participants, 466 (74%) reported regular use of mobile devices and 242 (39%) expressed an interest in supportive care information via smartphone applications. Patients under 45 were more likely to use a mobile device (Adjusted Odds Ratio [AOR] 6.8, 2.8‐16.9 95% CI, P < 0.001) and were interested in smartphone applications for delivery of information (AOR 3.2, 1.8‐5.9 95% CI, P < 0.001). Non‐white patients had similar use of mobile technology compared to whites but reported greater interest in smartphone application‐based information (AOR 3.4, 2.1‐5.5 95% CI, P < 0.001).

Conclusion

Many patients expressed interest in smartphone application‐based information about supportive care services, especially those who are younger and non‐white. Future studies should investigate the characteristics of patients and smartphones applications that will optimize information delivery through a mobile technology platform.

Keywords: cancer survivors, mobile technology, smartphone applications, supportive care, survivorship

1. INTRODUCTION

There are more than 15.5 million cancer survivors in the United States and this number is expected to rise to 20.3 million by 2026.1 Optimal care for this population goes beyond cancer treatment to include supportive care services to address common symptoms such as pain,2 fatigue,3 insomnia4, 5, and depressive symptoms.6 National Comprehensive Care Network (NCCN) guidelines for management of these symptoms recommend palliative care, cognitive behavioral therapy (CBT), mindfulness‐based stress reduction (MBSR), and supportive therapies. However, 30%‐60% of cancer patients have unmet supportive care needs7, 8 and these unmet needs may increase over time.9

Utilization of supportive care services among cancer survivors is low, ranging from 2% to 50%.7, 10 Barriers to use of these services often include lack of provider referral and lack of awareness.10 Cancer patients have been shown to have significant need for education and information around survivorship.11, 12 To better inform survivors of supportive care services, optimization of information delivery is needed.

Optimal methods for information delivery to cancer survivors are not clear. Patients in rural areas have expressed a preference for electronic formats for ongoing contact13 but there is little evidence informing optimal delivery mechanisms and there are organizational challenges with electronic communication of health care.14 Newer technologies, such as mobile phones, have been rapidly adopted with 77% of American adults owning a smartphone, up from 35% in 2011.15 In a general population, it has been shown that interest in mobile technologies was associated with greater depression and worse quality of life as well as greater self‐efficacy.16 Other conditions, such as pregnancy,17 smoking cessation18, and diabetes,19 have made use of mobile technologies to aid in information delivery in high‐need populations. Use of and interest in mobile technologies in the cancer survivor population specifically has not been described. These technologies are an opportunity for new and more efficient dissemination of supportive care information to cancer survivors.

Given the need for better information about symptom management among cancer survivors and the wide use of mobile technology, we set out to describe use and interest in smartphone applications for information delivery in the survivor population.

2. METHODS

2.1. Survey design and patients

We conducted a cross‐sectional survey study at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, PA, and Penn Cancer Network community hospitals in suburban and rural areas of Pennsylvania, New Jersey, and Delaware (Cape May Regional Hospital (Cape May, NJ); Chester Hospital (West Chester, PA); Community Medical Center (Toms River, NJ); Doylestown Hospital (Doylestown, PA); Kennedy Hospital, Kennedy Health Center (Cherry Hill, NJ); Kent General Hospital (Dover, DE); Lancaster General Health (Lancaster, PA); Milford Memorial Hospital (Milford, DE); Monmouth Medical Center (Longbranch, NJ); Pennsylvania Hospital (Philadelphia, PA); and Phoenixville Hospital (Phoenixville, PA) between December 2014 and September 2015. Research staff evaluated the eligibility criteria, approached patients during regular clinical visits, performed informed consent process and conducted the survey study. Patients were required to be 18 years of age or older, have a primary diagnosis of cancer, have a Karnofsky functional score of 60 or greater (ie ambulatory), understand written English, verbally indicate to the research staff that they felt physically well enough to complete a survey at the time of approach, and report experiencing nonzero pain (on a scale of 0‐10) in the last seven days. The Institutional Review Board of the University of Pennsylvania and the Scientific Review and Monitoring Committee of the Abramson Cancer Center approved the study protocol and surveys.

2.2. Outcomes

Mobile technologies were defined as smartphones, tablets, or text messaging. Patients reported frequency of use on a 5‐point Likert scale—never, less than once/month, less than once/week, at least once/week and daily. We defined regular use as patient reported utilization at least once per week or daily.

Interest in smartphone applications for information delivery format was measured on a 4‐point Likert scale, from very unimportant to very important; we defined a given communication method as “of interest” if patients rated it as important or very important.

Patients self‐reported date of cancer diagnosis and demographic factors including age, sex, race, education, and marital status. We dichotomized education to high school or less and college or above. We determined cancer type and stage from chart abstractions and dichotomized stage to metastatic and non‐metastatic. Patients reported if they had received surgery, chemotherapy, and/or radiation.

2.3. Statistical analysis

We performed statistical analysis using STATA software (Windows version 12.0, StatCorpLP, College Station, TX). We used univariate Chi2 testing to identify factors associated with mobile technology use and preference. We then conducted multivariate logistic regression analyses to identify factors associated with use and preference for mobile technology. We incorporated variables that were significant at P = 0.10 in the univariate Chi2 analysis. All analyses were two‐sided with p less than 0.05 indicating statistical significance in the multivariate model.

3. RESULTS

3.1. Demographics and clinical characteristics of study participants

Among the 631 participants, mean age was 60.3 years (range 23.1‐90.4), 415 (65.8%) were female, 521 (82.6%) white, 312 (53.8%) had non‐metastatic cancer, and approximately half (51.8%) were seen in community hospitals (Table 1). Most (n = 427, 68.2%) had completed at least some time in college, and 65.8% (n = 415) reported they were married or currently living with a partner. The most common cancer types were breast (n = 202, 32%), followed by thoracic, hematologic, and gastrointestinal. Nearly half (n = 303, 49.6%) of patients had been diagnosed in the 12 months prior to completing the survey, with 20.6% (n = 126) diagnosed within 12 to 36 months; 182 (29.8%) had been diagnosed more than 36 months before taking the survey. Most (n = 556, 88.1%) were treated with chemotherapy and about half had received surgery (n = 336, 53.3%) and radiation (n = 335, 53.1%).

Table 1.

Characteristics of all survey participants (N = 631)

Characteristic N %
Age
>65 225 35.7
56‐65 200 31.7
46‐55 136 21.6
≤45 70 11.1
Sex
Female 415 65.8
Male 216 34.2
Race
White 521 82.6
Non‐White 110 17.4
Education
High school or less 199 31.8
College or above 427 68.2
Marital Status
Not married 216 34.2
Married/living with partner 415 65.8
Cancer type
Breast 202 32.0
Gastro‐Intestinal 81 12.8
Genito‐Urinary 36 5.7
Gynecologic 47 7.5
Head/Neck 53 8.4
Hematologic 93 14.7
Thoracic 93 14.7
Other 26 4.1
Cancer stage
Non‐metastatic 312 53.8
Metastatic 268 46.2
Time since diagnosis
≤12 mo 303 49.6
12‐36 mo 126 20.6
>36 mo 182 29.8
Surgery
No 295 46.7
Yes 336 53.3
Chemotherapy
No 75 11.9
Yes 556 88.1
Radiation
No 296 46.9
Yes 335 53.1
Worst pain
Mild 170 27.1
Moderate 148 23.6
Severe 309 49.3
Location of treatment
Academic hospital 304 48.2
Community hospital 327 51.8

3.2. Use and determinants of use of mobile technologies

Among 631 respondents, 466 (73.9%) regularly used mobile technologies including smartphones (n = 356, 57%), tablets (n = 240, 38%), and text messaging (n = 418, 66%). Younger patients were more likely to report regular use of mobile technologies (91.4% for age ≤45 years, 89.0% for age 46‐55, 78.5% for age 56‐65 and 55.1% for age > 65) (Table 2). In addition, patients with at least some college education (79.6% vs 60.8% with high school education or less, P < 0.001), women (76.4% vs 69.0% of men, P = 0.045), and patients seen at an academic hospital (78.9% vs 69.1% of those treated at community hospitals, P = 0.005) were more likely to report regular use of mobile technologies. In multivariate analysis, patients under 45 years old were substantially more likely to use mobile technologies ([AOR] 6.8, 2.8‐16.9 95% CI, P < 0.001) than those aged older than 65 years (Table 3). Those with college or above education were also more likely to use mobile technologies than those with high school education or less (AOR 2.3, 1.5‐3.5 95% CI, P < 0.001). There was no difference in mobile technology use across races.

Table 2.

Demographic/clinical factors and mobile device use and smartphone application interest

Characteristic Mobile device usage Smartphone interest
N % P‐value N % P‐value
Age
>65 124 55.1 <0.001 61 28.0 <0.001
56‐65 157 78.5 70 35.4
46‐55 121 89.0 69 51.1
≤45 64 91.4 42 60.0
Sex
Female 317 76.4 0.045 155 37.9 0.45
Male 149 69.0 87 41.0
Race
White 383 73.5 0.67 175 34.0 <0.001
Non‐White 83 75.5 67 63.2
Education
High school or less 121 60.8 <0.001 65 32.8 0.036
College or above 340 79.6 174 41.6
Marital Status
Not married 147 68.1 0.017 84 39.4 0.86
Married/living with partner 319 76.9 158 38.7
Cancer type
Breast 164 81.2 0.010 80 40.0 0.24
Gastro‐intestinal 65 80.2 37 45.7
Genito‐urinary 28 77.8 17 47.2
Gynecologic 34 72.3 18 39.1
Head/Neck 39 73.6 15 29.4
Hematologic 59 63.4 31 34.8
Thoracic 59 63.4 30 32.6
Other 18 69.2 14 53.8
Cancer Stage
Non‐metastatic 236 75.6 0.43 118 38.6 0.91
Metastatic 195 72.8 103 39.0
Time since diagnosis
<12 mo 216 71.3 0.16 114 37.9 0.88
12‐36 mo 101 80.2 49 39.8
>36 mo 136 74.7 71 39.9
Treatment—surgery
No 195 66.1 <0.001 101 34.7 0.041
Yes 271 80.6 141 42.7
Treatment—chemotherapy
No 52 69.3 0.34 33 44.0 0.34
Yes 414 74.5 209 38.3
Treatment—radiation
No 217 73.3 0.77 116 40.1 0.58
Yes 249 74.3 126 37.9
Worst pain
Mild 128 75.3 0.26 57 34.8 0.18
Moderate 115 77.7 66 44.9
Severe 219 70.9 117 38.2
Location of treatment
Academic hospital 240 78.9 0.005 128 43.0 0.051
Community hospital 226 69.1 114 35.3

Values found to be significant to P < 0.05 are bolded.

Table 3.

Multivariate analysis of mobile device use and smartphone interest

Mobile device usage Smartphone Interest
A.O.R. (95% C.I.) P‐value A.O.R. (95% C.I.) P‐value
Age
>65 1 1
56‐65 2.8 (1.8‐4.4) <0.001 1.2 (0.8‐1.9) 0.33
46‐55 6.2 (3.3‐11.5) <0.001 2.7 (1.6‐4.3) <0.001
≤45 6.8 (2.8‐16.9) <0.001 3.2 (1.7‐5.9) <0.001
Sex
Female 1 1
Male 0.7 (0.5‐1.1) 0.16 1.6 (1.1‐2.4) 0.016
Race
White 1 1
Non‐white 0.9 (0.5‐1.6) 0.72 3.4 (2.1‐5.5) <0.001
Education
High school or less 1 1
College or above 2.3 (1.5‐3.5) <0.001 1.4 (1.0‐2.1) 0.076
Marital Status
Not married 1 1
Married/living with partner 1.6 (1.0‐2.4) 0.032 1.0 (0.7‐1.5) 1
Treatment—surgery
No 1 1
Yes 1.6 (1.1‐2.4) 0.022 1.5 (1.1‐2.2) 0.021
Location of treatment
Academic hospital 1 1
Community hospital 0.8 (0.6‐1.3) 0.43 1.0 (0.7‐1.4) 0.99

Values found to be significant to P < 0.05 are bolded.

3.3. Determinants of interest in smartphone applications

Overall, 242 (39%) patients expressed interest in smartphone applications to learn about supportive care services, with more younger patients reporting this interest (60.0% for age ≤45 vs 28.0% for age >65, P < 0.001). There was no significant difference in interest between genders, with 37.9% of women and 41.0% of men expressing interest in information delivery via smartphone application (P = 0.45). Interest varied by race with 34.0% of white patients and 63.2% of non‐white patients expressing interest in information delivery of supportive care services by smartphone application (P < 0.001). Of those with a high school education or less, 32.8% expressed an interest in smartphone application‐delivered information compared with while 41.6% of those with college or above (P = 0.036; Table 2).

In multivariate logistic analysis, younger age (AOR 3.2 for age ≤45 compared to >65, 1.7‐5.9 95% CI, P < 0.001), non‐white race (AOR 3.4, 2.1‐5.5 95% CI, P < 0.001), and male gender (AOR 1.6, 1.1‐2.4 95% CI, P = 0.016) were associated with an interest in receiving supportive care information through smartphone applications. Interest in information via smartphone app was similar across education groups (Table 3).

4. DISCUSSION

Our data demonstrate high levels of mobile technology use, particularly among younger cancer survivors. Non‐white patients, younger patients and male patients reported more interest in delivery of information through smartphone applications. While overall mobile technology use is similar to that reported for the general population,15 variations in interest and reported use among patients have implications for the design of mobile technology approaches to information delivery regarding supportive care.

Adolescent and young adult cancer patients have been found to have poorer physical and emotional well‐being compared to healthy controls.20 Greater awareness of supportive care services could ameliorate this outcome. It is not surprising to find younger patients have an interest in smartphone applications for the delivery of important information regarding supportive care services. In the adolescent and young adult (AYA) population, the proportion reporting smartphone use approaches 94%.15 Many may not remember a time before the internet and smartphones.21 Though the AYA survivor often uses mobile and internet technology to guide healthy behaviors, Mooney et al22 showed that much of the information they found did not meet their needs. Our results encourage further evaluation of mobile applications to educate this less‐informed population about potential supportive care interventions.

Our findings with regards to race are interesting and are reflective of other studies. In a national telephone survey study of cancer information seeking behavior, social determinants of race, ethnicity and social class affected preference for information sources.23 It is known that non‐white cancer survivors experience lower health‐related quality of life (HRQOL),24 are more likely to be obese25 and experience a physical limitation26 and poorer patient‐provider communication.27 More specific communications tailored to characteristics such gender, language, health literacy, and culture may improve uptake of recommended interventions.28, 29, 30 Our study shows a significant interest in smartphone applications, particularly in a non‐white population. Increased use of technology, such as online patient portals, for communication31, 32 indicates potential to utilize mobile technology to increase awareness of supportive care services, decrease barriers, and improve health outcomes in cancer patients.

There are several limitations to our study. In this survey‐based study, there is the potential for recall bias and results should be interpreted with caution. However, survey responses regarding preference require little recall and are relevant for guiding information delivery. Selection bias is possible although our recruitment across academic and community centers and high response rate are reassuring. The survey tool was developed and administered in an English‐speaking population, which may lead to underrepresentation of certain cultural groups and results may not be generalizable to a non‐English speaking population. Nonetheless, our study indicates there are differences among a general cancer population in mobile technology use and smartphone application interest.

Our results point to an interest in information delivery via smartphone applications, particularly in younger and non‐white populations. There is still a gap in understanding why there is an interest in mobile technology for information delivery and how to further improve smartphone applications to serve in supportive care. With further research, our findings suggest it is possible to optimize mobile technology to aid in delivery of evidence‐based recommendations to underserved populations.

CONFLICTS OF INTEREST

There are no conflicts of interest disclosures from any authors.

ACKNOWLEDGMENTS

Research related to the development of this paper was supported in part by the National Cancer Institute grants to the University of Pennsylvania Abramson Cancer Center (2P30CA016520‐40) and the Memorial Sloan Kettering Cancer Center (3P30CA008748‐50), the Byrne Fund, the Translational and Integrative Medicine Research Fund at Memorial Sloan Kettering Cancer Center and the NIH/NCATS Grant KL2TR002385. The content is solely the responsibility of the authors and does not necessarily represent official views of the National Institutes of Health. The authors would like to thank the cancer survivors, oncologists, nurses, and clinical staff at all study sites for their contributions to this study.

Raghunathan NJ, Korenstein D, Li QS, Tonorezos ES, Mao JJ. Determinants of mobile technology use and smartphone application interest in cancer patients. Cancer Med. 2018;7:5812–5819. 10.1002/cam4.1660

REFERENCES

  • 1. Katapodi MC, Munro ML, Pierce PF, Williams RA. Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer. Nurs Res. 2011;60(6):368‐377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. van den Beuken‐van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan‐Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta‐analysis. J Pain Symptom Manage. 2016;51(6):1070‐1090.e1079. [DOI] [PubMed] [Google Scholar]
  • 3. Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S. Cancer‐related fatigue: evolving concepts in evaluation and treatment. Cancer. 2003;98(9):1786‐1801. [DOI] [PubMed] [Google Scholar]
  • 4. Miaskowski C, Paul SM, Cooper BA, et al. Predictors of the trajectories of self‐reported sleep disturbance in men with prostate cancer during and following radiation therapy. Sleep. 2011;34(2):171‐179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Liu L, Rissling M, Natarajan L, et al. The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy. Sleep. 2012;35(2):237‐245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta‐analysis of diagnostic interviews and self‐report instruments. Psychooncology. 2014;23(2):121‐130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Armes J, Crowe M, Colbourne L, et al. Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009;27(36):6172‐6179. [DOI] [PubMed] [Google Scholar]
  • 8. Bender JL, Wiljer D, To MJ, et al. Testicular cancer survivors’ supportive care needs and use of online support: a cross‐sectional survey. Support Care Cancer. 2012;20(11):2737‐2746. [DOI] [PubMed] [Google Scholar]
  • 9. McDowell ME, Occhipinti S, Ferguson M, Dunn J, Chambers SK. Predictors of change in unmet supportive care needs in cancer. Psychooncology. 2010;19(5):508‐516. [DOI] [PubMed] [Google Scholar]
  • 10. Eakin EG, Strycker LA. Awareness and barriers to use of cancer support and information resources by HMO patients with breast, prostate, or colon cancer: patient and provider perspectives. Psychooncology. 2001;10(2):103‐113. [DOI] [PubMed] [Google Scholar]
  • 11. Burg MA, Adorno G, Lopez ED, et al. Current unmet needs of cancer survivors: analysis of open‐ended responses to the American Cancer Society Study of Cancer Survivors II. Cancer. 2015;121(4):623‐630. [DOI] [PubMed] [Google Scholar]
  • 12. Hoekstra RA, Heins MJ, Korevaar JC. Health care needs of cancer survivors in general practice: a systematic review. BMC Family Pract. 2014;15:94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Smith SL, Singh‐Carlson S, Downie L, Payeur N, Wai ES. Survivors of breast cancer: patient perspectives on survivorship care planning. J Cancer Surviv. 2011;5(4):337‐344. [DOI] [PubMed] [Google Scholar]
  • 14. Das A, Faxvaag A. The Impact of an eHealth Portal on Health Care Professionals’ Interaction with Patients: Qualitative Study. J Med Internet Res. 2015;17(11):e267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Mobile Fact Sheet. February 5, 2018. http://www.pewinternet.org/fact-sheet/mobile/#. Accessed February 28, 2018
  • 16. Featherall J, Lapin B, Chaitoff A, Havele SA, Thompson N, Katzan I. Characterization of patient interest in provider‐based consumer health information technology: survey study. J Med Internet Res. 2018;20(4):e128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Tiase VL, Licata M, Fleck EM. Preliminary findings of the delivery of the national diabetes prevention program via a mobile application. Stud Health Technol Inform. 2016;225:1034‐1035. [PubMed] [Google Scholar]
  • 18. Ghorai K, Akter S, Khatun F, Ray P. mHealth for smoking cessation programs: a systematic review. J Personal Med. 2014;4(3):412‐423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Kim HS, Choi W, Baek EK, et al. Efficacy of the smartphone‐based glucose management application stratified by user satisfaction. Diabet Metab J. 2014;38(3):204‐210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Salsman JM, Garcia SF, Yanez B, Sanford SD, Snyder MA, Victorson D. Physical, emotional, and social health differences between posttreatment young adults with cancer and matched healthy controls. Cancer. 2014;120(15):2247‐2254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Ritterband LM, Andersson G, Christensen HM, Carlbring P, Cuijpers P. Directions for the International Society for Research on Internet Interventions (ISRII). J Med Internet Res. 2006;8(3):e23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Mooney R, Samhouri M, Holton A, et al. Adolescent and young adult cancer survivors’ perspectives on their internet use for seeking information on healthy eating and exercise. J Adolesc Young Adult Oncol. 2016;6:367‐371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Viswanath K, Ackerson LK. Race, ethnicity, language, social class, and health communication inequalities: a nationally‐representative cross‐sectional study. PLoS ONE. 2011;6(1):e14550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Rosales M, Ashing K, Napoles A. Quality of cancer follow‐up care: a focus on Latina breast cancer survivors. J Cancer Surviv. 2014;8(3):364‐371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Stolley MR, Sharp LK, Tangney CC, et al. Health behaviors of minority childhood cancer survivors. Cancer. 2015;121(10):1671‐1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Gallicchio L, Calhoun C, Helzlsouer KJ. Association between race and physical functioning limitations among breast cancer survivors. Support Care Cancer. 2014;22(4):1081‐1088. [DOI] [PubMed] [Google Scholar]
  • 27. Palmer NR, Kent EE, Forsythe LP, et al. Racial and ethnic disparities in patient‐provider communication, quality‐of‐care ratings, and patient activation among long‐term cancer survivors. J Clin Oncol. 2014;32(36):4087‐4094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Robertson MC, Tsai E, Lyons EJ, et al. Mobile health physical activity intervention preferences in cancer survivors: a qualitative study. JMIR mHealth uHealth. 2017;5(1):e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Kreps GL, Neuhauser L. New directions in eHealth communication: opportunities and challenges. Patient Educ Couns. 2010;78(3):329‐336. [DOI] [PubMed] [Google Scholar]
  • 30. Banas JR, Victorson D, Gutierrez S, Cordero E, Guitleman J, Haas N. Developing a Peer‐to‐Peer mHealth application to connect hispanic cancer patients. J Cancer Educat. 2017;32(1):158‐165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Cronin RM, Davis SE, Shenson JA, Chen Q, Rosenbloom ST, Jackson GP. Growth of secure messaging through a patient portal as a form of outpatient interaction across clinical specialties. Appl Clin Inform. 2015;6(2):288‐304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Peacock S, Reddy A, Leveille SG, et al. Patient portals and personal health information online: perception, access, and use by US adults. J Am Med Inform Assoc. 2017;24(e1):e173‐e177. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Medicine are provided here courtesy of Wiley

RESOURCES